Home » Healthcare » Pharmaceuticals » UAE Gastrointestinal Products Market

UAE Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
UAE Gastrointestinal Products Market Size 2023	USD 30.95 million
UAE Gastrointestinal Products Market, CAGR	3.69%
UAE Gastrointestinal Products Market Size 2032	USD 42.97 million

Market Overview

The UAE Gastrointestinal Products Market is projected to grow from USD 30.95 million in 2023 to USD 42.97 million by 2032, with a compound annual growth rate (CAGR) of 3.69%.

The UAE gastrointestinal products market is driven by the rising prevalence of gastrointestinal disorders, an aging population, and increased healthcare awareness. As lifestyle changes and dietary habits contribute to conditions like irritable bowel syndrome, acid reflux, and ulcers, the demand for effective treatments is growing. Additionally, the expansion of healthcare infrastructure and government initiatives to improve medical services are fueling market growth. Advances in pharmaceutical formulations and the development of more targeted therapies are enhancing treatment options, further supporting market expansion. Moreover, the rising adoption of over-the-counter gastrointestinal medications and a growing trend toward natural and herbal remedies are reshaping consumer preferences. The UAE’s position as a healthcare hub in the Middle East, coupled with a well-established medical tourism industry, also contributes to the market’s positive outlook. These factors, along with innovations in drug delivery systems, are expected to drive continued growth in the coming years.

The UAE gastrointestinal products market is primarily driven by the increasing demand for advanced medical devices and treatments, supported by a well-established healthcare infrastructure. Key players in the region include global leaders such as KARL STORZ, Boston Scientific, Fujifilm, Medtronic, and Stryker, which offer a range of diagnostic and therapeutic solutions for gastrointestinal disorders. These companies are well-positioned in the UAE market, with their innovative products catering to the growing need for high-quality gastrointestinal care. Additionally, local players and distributors contribute to the market’s expansion by ensuring the availability of these products across the UAE’s diverse healthcare facilities. The market benefits from the UAE’s strategic position as a medical hub in the Middle East, attracting both regional and international patients, further boosting the demand for gastrointestinal products. As the healthcare sector continues to advance, these key players are likely to see sustained growth in the region.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The UAE gastrointestinal products market was valued at USD 30.95 million in 2023 and is projected to reach USD 42.97 million by 2032, growing at a CAGR of 3.69%.
Increasing prevalence of gastrointestinal disorders, such as acid reflux and IBS, is driving demand for advanced diagnostic and therapeutic products.
Rising healthcare awareness and adoption of preventive healthcare measures are boosting market growth, especially for natural and OTC products.
Technological advancements in gastrointestinal devices, such as endoscopy and motility testing devices, are shaping market trends.
Key players like KARL STORZ, Boston Scientific, and Medtronic dominate the market with innovative solutions and strong distribution networks.
Regulatory hurdles and high treatment costs limit broader adoption of gastrointestinal products in certain regions of the UAE.
The market is expanding in major cities like Dubai and Abu Dhabi, with steady growth in smaller emirates like Sharjah and Fujairah.

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The increasing incidence of gastrointestinal disorders, such as irritable bowel syndrome (IBS), acid reflux, Crohn’s disease, and peptic ulcers, is a major driver of the UAE gastrointestinal products market. For instance, one fifth of the UAE population suffers from gastrointestinal diseases, including acid reflux and irritable bowel syndrome. Rapid urbanization, poor dietary habits, and sedentary lifestyles have led to a rise in these conditions, resulting in a higher demand for effective gastrointestinal treatments. As the population becomes more health-conscious, the need for both over-the-counter and prescription medications to manage these disorders is growing.

Aging Population and Healthcare Demands

The aging population in the UAE is contributing significantly to the market’s growth. As people age, they become more susceptible to gastrointestinal diseases, particularly conditions like constipation, acid reflux, and other digestive issues. For example, the number of people over 65 in the UAE is expected to increase significantly by 2050, creating greater demand for healthcare services. The elderly demographic, combined with an increase in life expectancy, is expanding the consumer base for gastrointestinal products. Furthermore, the demand for specialized care and treatment options for older adults is boosting market growth as healthcare providers focus on improving the quality of life for the aging population.

Healthcare Infrastructure and Government Initiatives

The UAE government’s efforts to improve healthcare infrastructure and access to medical treatments are also propelling the gastrointestinal products market. Initiatives such as the UAE Vision 2021 and National Health Strategy 2050 aim to provide high-quality healthcare services to citizens and residents. Enhanced medical facilities, coupled with advancements in healthcare technology, are increasing the availability of gastrointestinal treatments. This has led to a more accessible and efficient treatment process, contributing to market growth.

Innovation in Pharmaceutical Products

Ongoing advancements in pharmaceutical formulations and the development of innovative gastrointestinal drugs are fueling market expansion. Companies are investing in research and development to introduce more effective and targeted treatments for various gastrointestinal conditions. Additionally, the trend toward natural and herbal remedies, coupled with improvements in drug delivery systems, is reshaping the treatment landscape. These innovations are driving consumer interest, providing more options, and contributing to market growth in the UAE.

Market Trends

Growing Preference for Over-the-Counter Products

One of the key trends in the UAE gastrointestinal products market is the increasing preference for over-the-counter (OTC) medications. Consumers are becoming more proactive in managing their health, opting for readily accessible and affordable gastrointestinal products to treat conditions such as acid reflux, indigestion, and constipation. For instance, a report highlighted that the UAE’s OTC pharmaceuticals market is expanding due to the convenience and accessibility of these products. The convenience of purchasing OTC products without a prescription is appealing, especially as the healthcare system becomes more consumer-centric. This shift toward self-medication is expected to continue driving the demand for gastrointestinal products in the UAE.

Rising Popularity of Natural and Herbal Remedies

There is a growing trend in the UAE towards natural and herbal gastrointestinal products. Consumers are increasingly seeking organic and plant-based alternatives to traditional pharmaceutical drugs due to a heightened awareness of the side effects of synthetic medications. Herbal supplements, probiotics, and dietary changes are becoming preferred methods for managing digestive issues. This trend reflects broader consumer preferences for healthier, more sustainable lifestyle choices, influencing the types of gastrointestinal products gaining traction in the market.

Integration of Digital Health Solutions

The integration of digital health solutions is another trend shaping the UAE gastrointestinal products market. With the rise of telemedicine and mobile health applications, patients are now able to consult healthcare providers remotely and gain access to personalized treatment plans for gastrointestinal conditions. Digital platforms also offer consumers the ability to track their symptoms, receive timely advice, and monitor their progress, making it easier for them to manage their digestive health. This trend is increasing patient engagement and influencing the adoption of innovative treatment options in the gastrointestinal sector.

Growth of Medical Tourism in the UAE

The UAE’s growing reputation as a medical tourism hub is also driving the demand for gastrointestinal products. Patients from around the region and beyond are visiting the UAE for high-quality treatment and procedures, including gastrointestinal care. The country’s world-class healthcare facilities, advanced medical technologies, and skilled professionals are attracting international patients, contributing to the market growth. As more people seek specialized care, there is a rising demand for a diverse range of gastrointestinal products tailored to various needs and preferences.

Market Challenges Analysis

Regulatory and Compliance Challenges

A major challenge facing the UAE gastrointestinal products market is the complex regulatory environment. The government’s stringent regulations on the approval and distribution of pharmaceutical products, including gastrointestinal medications, can create hurdles for manufacturers and distributors. For instance, the Ministry of Health and Prevention (MoHAP) and the Emirates Authority for Standardization and Metrology (ESMA) enforce rigorous standards to ensure drug safety and efficacy. Navigating the approval processes for new products and ensuring compliance with local standards can be time-consuming and costly. Additionally, the market is highly competitive, with numerous international brands vying for market share, further complicating the regulatory landscape. Manufacturers must adhere to strict guidelines to ensure product safety, efficacy, and quality, which can delay the introduction of new gastrointestinal products into the market.

High Cost of Healthcare and Treatment Accessibility

Despite the growing healthcare infrastructure in the UAE, the high cost of healthcare remains a significant barrier to the widespread use of gastrointestinal products. While government initiatives have improved access to healthcare services, the affordability of advanced gastrointestinal treatments, especially for chronic conditions, can be a challenge for a significant portion of the population. The cost of medications, medical consultations, and diagnostic procedures may limit access to essential treatments, particularly among low to middle-income individuals. This economic disparity creates a challenge for market expansion, as not all segments of the population can afford the latest gastrointestinal products or therapies, potentially slowing the overall growth of the market.

Market Opportunities

Expansion of Telemedicine and Digital Health

The growing integration of telemedicine and digital health solutions presents significant opportunities for the UAE gastrointestinal products market. As the UAE continues to embrace digital health technologies, consumers have greater access to online consultations and personalized treatment plans for gastrointestinal conditions. This shift is not only enhancing patient care but also driving demand for gastrointestinal products, particularly in the form of digital monitoring devices, online prescriptions, and mobile health applications. Manufacturers and healthcare providers can capitalize on this trend by offering more innovative and accessible solutions that cater to the evolving needs of consumers. The adoption of digital health platforms in managing gastrointestinal disorders could also lead to increased patient engagement and improved adherence to treatments, further expanding market potential.

Increasing Focus on Preventative Healthcare

With the rising awareness of lifestyle-related diseases and the UAE’s focus on preventative healthcare, there is a significant opportunity to expand the market for gastrointestinal products. The growing consumer demand for preventative measures, such as probiotics, digestive health supplements, and diet-based solutions, is opening new avenues for growth. Companies can tap into this trend by offering products that help maintain optimal gastrointestinal health and prevent disorders before they arise. Additionally, with government initiatives emphasizing health promotion and wellness, there is an opportunity to introduce educational campaigns and health awareness programs that highlight the importance of digestive health. This proactive approach to healthcare will likely drive consumer interest in gastrointestinal products, contributing to market growth in the long term.

Market Segmentation Analysis:

By Devices:

The UAE gastrointestinal products market is segmented by devices, including endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices. Endoscopy devices hold a significant share, driven by their widespread use in diagnosing and treating various gastrointestinal disorders such as gastrointestinal cancers, ulcers, and inflammatory bowel disease. Ablation devices are gaining traction due to their effectiveness in treating conditions like gastrointestinal cancers, providing a minimally invasive treatment option. Motility testing devices are also seeing increased demand as they aid in diagnosing motility disorders, such as irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). Biopsy devices, used for the diagnosis of conditions like gastrointestinal cancers, are essential in early disease detection, contributing to the market’s growth. Stenting devices, crucial for managing conditions like esophageal strictures and bowel obstructions, are gaining popularity due to their ability to improve patient outcomes and reduce the need for surgical interventions.

By Indications:
The market is also segmented based on indications, including gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other diseases. Gastrointestinal cancers, including colorectal and esophageal cancers, remain a key segment due to their high prevalence and the growing demand for advanced diagnostic and therapeutic devices. GERD and IBS are also prominent indications, with increasing cases driven by lifestyle changes and dietary habits in the UAE. The demand for products targeting these conditions is rising as consumers seek effective treatments. Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, is another critical segment, with increasing awareness and diagnosis rates. Products addressing these conditions are expected to see steady growth. Other diseases, including constipation, peptic ulcers, and diverticulosis, also contribute to the market’s expansion, as patients seek comprehensive solutions for digestive health management.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Abu Dhabi
Dubai
Sharjah
Ajman
Fujairah
Ras Al Khaimah
Umm Al Quwain

Regional Analysis

Abu Dhabi

Abu Dhabi holds a substantial portion, accounting for approximately 35% of the total market, due to its robust healthcare infrastructure and high demand for advanced medical treatments. The emirate’s strong healthcare sector, including top-tier hospitals and specialized centers, supports the growth of gastrointestinal products, particularly diagnostic devices and therapeutic treatments for conditions like gastrointestinal cancers and irritable bowel syndrome (IBS).

Dubai

Dubai, with its growing medical tourism industry and cosmopolitan population, is close behind, representing about 40% of the market share. Dubai’s status as a healthcare hub in the Middle East, combined with its state-of-the-art facilities and government initiatives to improve healthcare accessibility, drives demand for gastrointestinal products, especially among expatriates and international patients seeking specialized care.

Sharjah

Sharjah, with a market share of approximately 15%, is experiencing an increase in the prevalence of gastrointestinal diseases, such as gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD), which is driving the demand for both therapeutic treatments and diagnostic devices. The emirate’s expanding healthcare infrastructure and proximity to Dubai contribute to its growing market for gastrointestinal products.

Ajman

Ajman, though a smaller player with a market share of around 5%, is benefiting from rising healthcare awareness and demand for affordable gastrointestinal treatments. As Ajman continues to develop its healthcare system and attract more healthcare providers, the demand for gastrointestinal products in the region is expected to grow steadily.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

KARL STORZ
Boston Scientific
Fujifilm
Ethicon Endo-Surgery
Medtronic
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The UAE gastrointestinal products market is highly competitive, with several leading players offering advanced solutions for diagnostic and therapeutic applications. Key players such as KARL STORZ, Boston Scientific, Fujifilm, Medtronic, Stryker, Smith & Nephew, Ethicon Endo-Surgery, and Hoya are prominent in the market, providing a wide range of gastrointestinal devices, including endoscopy, ablation, biopsy, and motility testing devices. Companies are focusing on innovation, with a particular emphasis on minimally invasive technologies such as endoscopy, ablation, and motility testing devices. As the market evolves, businesses are expanding their product portfolios to cater to a diverse range of gastrointestinal conditions, from cancers to irritable bowel syndrome. In addition to product innovation, companies are investing heavily in research and development to offer improved treatment options and stay ahead of emerging trends, such as personalized medicine and digital health integration. Strong distribution networks and collaborations with healthcare providers and medical institutions also play a crucial role in maintaining a competitive edge. For instance, Scope Investment and Asan Medical Center have partnered to establish the UAE’s first comprehensive Gastroenterology Hospital, which will provide advanced treatments and procedures. However, the market remains highly fragmented, with various regional players capitalizing on the growing demand for affordable solutions, which may pose a challenge for larger international firms. The competitive environment is also shaped by regulatory challenges, as companies need to navigate strict healthcare standards and certification processes. This ensures that only high-quality, safe products are introduced to the market, creating an opportunity for firms to distinguish themselves through superior product offerings and reliable customer support services.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The UAE gastrointestinal products market exhibits a moderate level of market concentration, with a mix of global and local players competing for market share. The market is primarily dominated by multinational companies that offer a wide range of advanced diagnostic and therapeutic solutions. These players leverage their established brand reputation, innovative technologies, and strong distribution networks to maintain dominance, particularly in the high-end segment of the market. While global companies hold a significant share, regional and local players are also emerging, providing affordable alternatives and catering to specific market needs. This has led to a growing competitive landscape, with companies increasingly focusing on product differentiation, including the development of minimally invasive technologies and digital health solutions. The characteristics of the market are driven by a high demand for quality healthcare services, a growing number of patients seeking advanced treatments, and a strong emphasis on technological advancements. The market is also characterized by rapid growth due to increasing awareness of gastrointestinal diseases, such as acid reflux, IBS, and gastrointestinal cancers. The regulatory environment is stringent, ensuring that only high-quality products are available in the market, which drives competition among companies to meet compliance standards while offering cutting-edge products. As the UAE healthcare sector continues to expand, market concentration is expected to increase, with more players striving for innovation and market leadership.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The UAE gastrointestinal products market is expected to grow steadily, driven by the increasing prevalence of gastrointestinal diseases.
Advancements in diagnostic technologies, such as digital endoscopy and AI-assisted imaging, will play a key role in market growth.
The demand for minimally invasive surgical solutions will continue to rise, enhancing patient outcomes and reducing recovery times.
Growing healthcare awareness and the adoption of preventive care measures will drive demand for gastrointestinal supplements and probiotics.
Increased government focus on healthcare infrastructure development will support the market’s expansion.
Technological innovation in gastrointestinal devices will result in more personalized and efficient treatments.
The rising healthcare expenditure and medical tourism in the UAE will attract global manufacturers to the market.
Regional players are expected to strengthen their position by offering cost-effective and localized products.
With a higher focus on gastrointestinal cancers, new treatment methods and products will emerge, further fueling market growth.
Regulatory improvements and streamlined certification processes will foster an environment conducive to market innovation and expansion.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. UAE GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by UAE 33

5.1.1. UAE GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By UAE, 2018 – 2023 33

5.2. Export Analysis by UAE 34

5.2.1. UAE GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By UAE, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by UAE 35

6.1.1. UAE GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By UAE, 2018 – 2023 35

6.2. Supply Analysis by UAE 36

6.2.1. UAE GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By UAE, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by UAE 37

7.1.1. UAE GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By UAE, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. UAE GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. UAE Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. UAE GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. UAE GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. UAE GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. UAE GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. UAE GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. UAE GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

UAE Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. KARL STORZ 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Boston Scientific 78

16.3. Fujifilm 78

16.4. Ethicon Endo-Surgery 78

16.5. Medtronic 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. UAE GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for UAE GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for UAE GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. UAE GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By UAE, 2018 – 2023 32

FIG NO. 5. UAE GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By UAE, 2018 – 2023 33

FIG NO. 6. UAE GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By UAE, 2018 – 2023 34

FIG NO. 7. UAE GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By UAE, 2018 – 2023 35

FIG NO. 8. UAE GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By UAE, 2018 – 2023 36

FIG NO. 9. UAE GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. UAE GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. UAE GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. UAE GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. UAE GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. UAE GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. UAE GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. UAE GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. UAE GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. UAE GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. UAE GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. UAE GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. UAE GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. UAE GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. UAE GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. UAE GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. UAE GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. UAE GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. UAE GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. UAE GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. UAE GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. UAE GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. UAE GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. UAE GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : UAE GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : UAE GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the UAE Gastrointestinal Products market?

The UAE gastrointestinal products market is valued at USD 30.95 million in 2023 and is projected to reach USD 42.97 million by 2032, reflecting a compound annual growth rate (CAGR) of 3.69%.

What factors are driving the growth of the UAE Gastrointestinal Products market?

The market growth is driven by the rising prevalence of gastrointestinal disorders such as acid reflux and IBS, an aging population, advancements in pharmaceutical formulations, and increased healthcare awareness. Government initiatives to enhance healthcare infrastructure and the growing trend toward preventive and natural remedies also contribute significantly.

What are the key segments within the UAE Gastrointestinal Products market?

The key segments include:
• By Devices: Endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices.
• By Indications: Gastrointestinal cancers, GERD, IBS, IBD, and other diseases.
• By End-User: Hospitals, ambulatory surgical centers, clinics, and other end users.
• By Geography: Major regions such as Abu Dhabi, Dubai, Sharjah, and other emirates.

What are some challenges faced by the UAE Gastrointestinal Products market?

Challenges include high treatment costs, limited affordability for advanced therapies, and complex regulatory processes for the approval and distribution of gastrointestinal products. These factors can hinder broader market adoption and delay the introduction of innovative treatments.

Who are the major players in the UAE Gastrointestinal Products market?

Major players include KARL STORZ, Boston Scientific, Fujifilm, Medtronic, Stryker, and Ethicon Endo-Surgery. These companies are recognized for their advanced diagnostic and therapeutic solutions, supported by strong distribution networks and innovative technologies.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –